IL-22R alpha 1 Antibody [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # AF4294E
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse IL-22 R alpha1
Thr18-Ala228
Accession # Q80XZ4
Thr18-Ala228
Accession # Q80XZ4
Specificity
Detects mouse IL‑22 R alpha1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 30% cross‑reactivity with recombinant human IL‑22 R is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for IL-22R alpha 1 Antibody [DyLight 405]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-22 R alpha 1
Long Name
Interleukin 22 Receptor
Alternate Names
CRF2-9, IL-22Ra1, IL-TIF-R1, IL22R alpha 1, IL22RA1
Gene Symbol
IL22RA1
Additional IL-22 R alpha 1 Products
Product Documents for IL-22R alpha 1 Antibody [DyLight 405]
Product Specific Notices for IL-22R alpha 1 Antibody [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...